Paediatrics

Ruxolitinib for preventing relapse of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

March 23, 2025 March 23, 2025

Pediatr Int. 2025 Jan-Dec;67(1):e70032. doi: 10.1111/ped.70032.

NO ABSTRACT

PMID:40121560 | DOI:10.1111/ped.70032

John Joseph

JohnJAcademy.com

View all posts by John Joseph